Responding to the national HIV/AIDS strategy-setting the research agenda

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 3, 2011, Pages 175-180

  Morin, Stephen F ^a   Kelly, Jeffrey A ^b   Charlebois, Edwin D ^a   Remien, Robert H ^c   Rotheram Borus, Mary J ^d   Cleary, Paul D ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; GOVERNMENT; HEALTH DISPARITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL CARE; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REVIEW; UNITED STATES;

ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; NATIONAL HEALTH PROGRAMS; RESEARCH DESIGN; UNITED STATES;

EID: 79959747167     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318222c0f9     Document Type: Review

References (63)

1. The White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States. Washington, DC: White House; 2010.
2. The White House Office of National AIDS Policy. National HIV/AIDS Strategy: Federal Implementation Plan. 2010. Available at: http://www. whitehouse.gov/files/documents/nhas-implementation.pdf.
3. The Office of National AIDS Policy (ONAP) is part of the White House Domestic Policy Council. http://www.whitehouse.gov/administration/eop/onap/ about. Accessed June 2011.
4. Millett GA, Crowley JS, Koh H, et al. A way forward: the National HIV/ AIDS Strategy and reducing HIV incidence in the United States. J Acquir Immune Defic Syndr. 2010;55(suppl 2):S144-S147.
5. Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008;372:669-684.
6. Vermund SH, Hodder SL, Justman JE, et al. Addressing research priorities for prevention of HIV infection in the United States. Clin Infect Dis. 2010; 50(suppl 3):S149-S155.
7. Castel A, Samala R, Griffin A, et al. Monitoring the impact of expanded HIV testing in the District of Columbia using population-based HIV/ AIDS surveillance data. In: Proceedings from the CROI. San Francisco, CA: February 16-19, 2010.
8. Mantsios A, Tsoi B, Futterman D, et al. Preliminary findings from a borough-wide initiative to scale up HIV screening in New York City. In: National HIV Prevention Conference. Atlanta, GA: 2009.
9. Khumalo-Sakutukwa G, Morin SF, Fritz K, et al. Project accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand. J Acquir Immune Defic Syndr. 2008;49:422-431.
10. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1-17; quiz CE1-4.
11. Patel P, Klausner JD, Bacon OM, et al. Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr. 2006;42:75-79. (Pubitemid 43947949)
12. El-Sadr WM, Mayer KH, Hodder SL. AIDS in America-forgotten but not gone. N Engl J Med. 2010;362:967-970.
13. Myers JJ, Modica C, Dufour MS, et al. Routine rapid HIV screening in six community health centers serving populations at risk. J Gen Intern Med. 2009;24:1269-1274.
14. CDC. Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas, 2008, in HIV Surveillance Report, Volume 20. Atlanta, GA: CDC; 2008.
15. Cohen MS, Pilcher CD. Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis. 2005;191:1391-1393. (Pubitemid 40563346)
16. Remien RH, Higgins JA, Correale J, et al. Lack of understanding of acute HIV infection among newly-infected persons-implications for prevention and public health: The NIMH Multisite Acute HIV Infection Study: II. AIDS Behav. 2009;13:1046-1053.
17. Steward WT, Remien RH, Higgins JA, et al. Behavior change following diagnosis with acute/early HIV infection-a move to serosorting with other HIV-infected individuals. The NIMHMultisite Acute HIV Infection Study: III. AIDS Behav. 2009;13:1054-1060.
18. Kelly JA, Morin SF, Remien RH, et al. Lessons learned about behavioral science and acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: V. AIDS Behav. 2009;13:1068-1074.
19. Institute of Medicine. HIV Screening and Access to Care. Washington, DC: Institute of Medicine of the National Academies; 2010.
20. Mugavero MJ. Improving engagement in HIV care: what can we do? Top HIV Med. 2008;16:156-161.
21. Fleming PL, Byers RH, Sweeney PA, et al. HIV Prevalence in the United States, 2000. In: 9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA; February 24-28, 2002.
22. Giordano TP, Visnegarwala F, White AC Jr., et al. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care. 2005;17:773-783. (Pubitemid 41113015)
23. Catz S, McClure J, Jones G, et al. Predictors of outpatient medical appointment attendance among persons with HIV. AIDS Care. 1999;11:361-373. (Pubitemid 29306691)
24. Israelski D, Gore-Felton C, Power R, et al. Sociodemographic characteristics associated with medical appointment adherence among HIV-seropositive patients seeking treatment in a county outpatient facility. Prev Med. 2001;33:470-475. (Pubitemid 33035790)
25. McClure JB, Catz SL, Brantley PJ. Early appointment adherence among persons living with HIV. AIDS Behav. 1999;3:157-165. (Pubitemid 29316242)
26. Sherer R, Stieglitz K, Narra J, et al. HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care. AIDS Care. 2002;14(suppl 1):S31-S44.
27. Ashman JJ, Conviser R, Pounds MB. Associations between HIV-positive individuals' receipt of ancillary services and medical care receipt and retention. AIDS Care. 2002;14(suppl 1):S109-S118.
28. Lo W, MacGovern T, Bradford J. Association of ancillary services with primary care utilization and retention for patients with HIV/AIDS. AIDS Care. 2002;14(suppl 1):S45-S57.
29. Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract. 1995;3:19-30.
30. Gary TL, Batts-Turner M, Bone LR, et al. A randomized controlled trial of the effects of nurse case manager and community health worker team interventions in urban African-Americans with type 2 diabetes. Control Clin Trials. 2004;25:53-66. (Pubitemid 38230103)
31. Kushel MB, Colfax G, Ragland K, et al. Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection. Clin Infect Dis. 2006;43:234-242.
32. Gardner LI, Metsch LR, Anderson-Mahoney P, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19:423-431. (Pubitemid 40446189)
33. HIV/AIDS Bureau. Outreach: Engaging People in HIV Care. Rockville, MD: HRSA; 2006.
34. Bradford JB, Coleman S, Cunningham W. HIV System Navigation: an emerging model to improve HIV care access. AIDS Patient Care STDS. 2007;21(suppl 1):S49-S58.
35. Giordano TP, Gifford AL, White AC Jr., et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44: 1493-1499. (Pubitemid 46801595)
36. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. 2010; PLoS One. 5:e11068.
37. DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Available at: http://www.aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf. Accessed May 27, 2011.
38. Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301:2380-2382.
39. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48-57.
40. Wagner BG, Kahn JS, Blower S. Should we try to eliminate HIV epidemics by using a "Test and Treat" strategy? AIDS. 2010;24: 775-776.
41. Dodd PJ, Garnett GP, Hallett TB. Examining the promise of HIV elimination by "test and treat" in hyperendemic settings. AIDS. 2010;24: 729-735.
42. Holtgrave DR. Potential and limitations of a "test and treat" strategy as HIV prevention in the United States. Int J Clin Pract. 2010;64: 678-681.
43. Walensky RP, Paltiel AD, Losina E, et al. Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis. 2010;51:392-400.
44. Charlebois ED, Das M, Porco TC, et al. The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco. Clin Infect Dis. 2011;52:1046-1049.
45. Montaner JS, Lima VD, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376:532-539.
46. Long EF, Brandeau ML, Owens DK. The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Ann Intern Med. 2010;153:778-789.
47. Simoni JM, Amico KR, Pearson CR, et al. Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep. 2008;10:515-521.
48. Simoni JM, Pantalone DW, Plummer MD, et al. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychol. 2007;26:488-495. (Pubitemid 47445006)
49. Antoni MH, Carrico AW, Duran RE, et al. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med. 2006;68:143-151. (Pubitemid 43803229)
50. Sorensen JL, Haug NA, Delucchi KL, et al. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007;88:54-63. (Pubitemid 46400307)
51. Remien RH, Stirratt MJ, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19:807-814. (Pubitemid 40834751)
52. Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721-728. (Pubitemid 32717795)
53. Ciesla JA, Roberts JE.Meta-analysis of the relationship between HIVinfection and risk for depressive disorders. Am J Psychiatry. 2001;158:725-730. (Pubitemid 32429839)
54. Grimley DM, Bachmann LH, JenckesMW, et al. Provider-delivered, theorybased, individualized prevention interventions for HIV positive adults receiving HIV comprehensive care. AIDS Behav. 2007;11(suppl):S39-S47. (Pubitemid 47319533)
55. Koester KA, Maiorana A, Vernon K, et al. Implementation of HIV prevention interventions with people living with HIV/AIDS in clinical settings: challenges and lessons learned. AIDS Behav. 2007;11(suppl): S17-S29. (Pubitemid 47319536)
56. Bachmann LH, Grimley DM, Chen H, et al. Risk behaviours in HIVpositive men who have sex with men participating in an intervention in a primary care setting. Int J STD AIDS. 2009;20:607-612.
57. Chen HT, Grimley DM, Waithaka Y, et al. A process evaluation of the implementation of a computer-based, health provider-delivered HIV-prevention intervention for HIV-positive men who have sex with men in the primary care setting. AIDS Care. 2008;20:51-60. (Pubitemid 351264541)
58. Marseille E, Shade SB, Myers J, et al. The cost-effectiveness of HIV prevention interventions for HIV-infected patients seen in clinical settings. J Acquir Immune Defic Syndr. 2011;56:87-94.
59. National Prevention Information Network. Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS: Phase II. 2011. Available at: http://www.cdcnpin.org/ scripts/Display/FundDisplay.asp?FundNbr=4308. Accessed May 27, 2011.
60. McKleroy VS, Galbraith JS, Cummings B, et al. Adapting evidence-based behavioral interventions for new settings and target populations. AIDS Educ Prev. 2006;18(suppl A):59-73. (Pubitemid 44440947)
61. Rotheram-Borus MJ, Klosinski LE, Etzel MA. Differences between proof-ofconcept studies and effective implementation: routine, opt-out HIV testing in emergency departments. J Acquir Immune Defic Syndr. 2007;46:381-383. (Pubitemid 350098686)
62. Schackman BR. Implementation science for the prevention and treatment of HIV/AIDS. J Acquir Immune Defic Syndr. 2010;55(suppl 1):S27-S31.
63. Norton WE, Amico KR, Cornman DH, et al. An agenda for advancing the science of implementation of evidence-based HIV prevention interventions. AIDS Behav. 2009;13:424-429.